Ad is loading...
KTTA
Price
$3.38
Change
+$0.08 (+2.42%)
Updated
Nov 15 closing price
RVNC
Price
$4.17
Change
-$0.14 (-3.25%)
Updated
Nov 15 closing price
106 days until earnings call
Ad is loading...

KTTA vs RVNC

Header iconKTTA vs RVNC Comparison
Open Charts KTTA vs RVNCBanner chart's image
Pasithea Therapeutics
Price$3.38
Change+$0.08 (+2.42%)
Volume$23.74K
CapitalizationN/A
Revance Therapeutics
Price$4.17
Change-$0.14 (-3.25%)
Volume$1.21M
CapitalizationN/A
KTTA vs RVNC Comparison Chart
Loading...
KTTA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RVNC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
KTTA vs. RVNC commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KTTA is a Sell and RVNC is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (KTTA: $3.38 vs. RVNC: $4.17)
Brand notoriety: KTTA and RVNC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KTTA: 2% vs. RVNC: 38%
Market capitalization -- KTTA: $3.53M vs. RVNC: $437.44M
KTTA [@Biotechnology] is valued at $3.53M. RVNC’s [@Biotechnology] market capitalization is $437.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KTTA’s FA Score shows that 1 FA rating(s) are green whileRVNC’s FA Score has 0 green FA rating(s).

  • KTTA’s FA Score: 1 green, 4 red.
  • RVNC’s FA Score: 0 green, 5 red.
According to our system of comparison, KTTA is a better buy in the long-term than RVNC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KTTA’s TA Score shows that 3 TA indicator(s) are bullish while RVNC’s TA Score has 4 bullish TA indicator(s).

  • KTTA’s TA Score: 3 bullish, 6 bearish.
  • RVNC’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, RVNC is a better buy in the short-term than KTTA.

Price Growth

KTTA (@Biotechnology) experienced а +2.11% price change this week, while RVNC (@Biotechnology) price change was +12.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

KTTA is expected to report earnings on Feb 28, 2024.

RVNC is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVNC($437M) has a higher market cap than KTTA($3.53M). RVNC (-52.560) and KTTA (-54.324) have similar YTD gains . KTTA has higher annual earnings (EBITDA): -16.27M vs. RVNC (-274.04M). RVNC has more cash in the bank: 232M vs. KTTA (7.97M). KTTA has less debt than RVNC: KTTA (0) vs RVNC (492M). RVNC has higher revenues than KTTA: RVNC (251M) vs KTTA (0).
KTTARVNCKTTA / RVNC
Capitalization3.53M437M1%
EBITDA-16.27M-274.04M6%
Gain YTD-54.324-52.560103%
P/E RatioN/AN/A-
Revenue0251M-
Total Cash7.97M232M3%
Total Debt0492M-
FUNDAMENTALS RATINGS
RVNC: Fundamental Ratings
RVNC
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KTTARVNC
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 5 days ago
70%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
79%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
KTTA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RVNC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TEMSX8.09N/A
N/A
Nuveen Emerging Markets Eq Retiremt
IGNIX17.25-0.05
-0.29%
Delaware Ivy Natural Resources I
FCLTX47.66-0.27
-0.56%
Fidelity Advisor Industrials M
LVAMX12.28-0.08
-0.65%
LSV US Managed Volatility Investor
UCNQX49.58-1.22
-2.40%
Victory Nasdaq 100 Index C

KTTA and

Correlation & Price change

A.I.dvisor tells us that KTTA and FATE have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KTTA and FATE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KTTA
1D Price
Change %
KTTA100%
+2.42%
FATE - KTTA
32%
Poorly correlated
-2.88%
ACET - KTTA
25%
Poorly correlated
-9.82%
SPRB - KTTA
24%
Poorly correlated
-5.83%
RVNC - KTTA
24%
Poorly correlated
-3.25%
TRAW - KTTA
24%
Poorly correlated
-10.59%
More

RVNC and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVNC has been loosely correlated with AXON. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if RVNC jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVNC
1D Price
Change %
RVNC100%
-3.25%
AXON - RVNC
39%
Loosely correlated
-0.86%
HRMY - RVNC
39%
Loosely correlated
+0.65%
ABCL - RVNC
37%
Loosely correlated
-3.99%
GOSS - RVNC
35%
Loosely correlated
-3.88%
NTLA - RVNC
34%
Loosely correlated
-7.61%
More